MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$888M
Free Cash flow
$814M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Cash provided by/(used in) inves...
Net income
Changes in assets and liabilitie...
Others
Negative Cash Flow Breakdown
(gains)/losses on asset sales an...
Repayment under paa term loan (n...
Net borrowings/(repayments) unde...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
1,815
222
407
504
Total revenues
-
294
397
920
Purchases and related costs
-
205
166
245
Total revenues
350
-
-
-
Field operating costs
-
71
69
190
Purchases and related costs
205
-
-
-
General and administrative expenses
-
14
11
36
Field operating costs
108
-
-
-
Depreciation and amortization
-
0
0
57
General and administrative expenses
17
-
-
-
Losses on asset sales and other, net
-
-32
-6
-15
Depreciation and amortization
0
-
-
-
Total costs and expenses
-
322
252
543
(gains)/losses on asset sales and other, net
1,605
-
-
-
Other income, net
-
-
0
-
Total costs and expenses
-1,275
-
-
-
Income/(loss) from discontinued operations before tax
-
-28
145
377
Income from discontinued operations before tax
1,625
-
-
-
Current income tax expense
71
44
38
61
Deferred income tax expense
-
31
5
35
Deferred income tax (expense)/benefit
-38
-
-
-
Income from discontinued operations, net of tax
1,651
-103
102
281
Depreciation and amortization
243
243
257
230
Losses on asset sales, asset impairments and other, net
-59
53
-10
93
Equity-indexed compensation expense
-
-
50
-
Deferred income tax expense/(benefit)
102
-208
26
25
(gain)/loss on foreign currency revaluation
16
-
6
-15
Settlement of terminated interest rate hedging instruments (note 13)
-
-
-30
-7
Change in fair value of preferred distribution rate reset option (note 13)
-
-
0
-
Equity earnings in unconsolidated entities
89
89
90
96
Distributions on earnings from unconsolidated entities
107
97
117
113
Gain on investments in unconsolidated entities, net (note 8, note 9)
-
-
0
0
Other
3
-30
33
-16
Trade accounts receivable and other
-
-
-207
-
Inventory
-
-
-96
-
Trade accounts payable and other
-
-
-337
-
Changes in assets and liabilities, net of acquisitions
-244
-37
-
-158
Cash provided by operating activities - continuing operations
811
400
614
804
Cash provided by operating activities - discontinued operations
141
18
170
13
Net cash provided by operating activities
952
418
784
817
Cash paid in connection with acquisitions, net of cash acquired
42
88
1,786
184
Investments in unconsolidated entities (note 9)
-
-
2
0
Additions to property, equipment and other
138
130
148
185
Cash paid for purchases of linefill
10
2
10
0
Proceeds from sales of assets
1
3
54
6
Cash received from sales of linefill
37
-
-
-
Other investing activities
-20
-
-
0
Cash used in investing activities - continuing operations
-132
-217
-1,892
-363
Cash provided by/(used in) investing activities - discontinued operations
3,467
-16
-46
-45
Net cash provided by/(used in) investing activities
3,335
-233
-1,938
-408
Net borrowings/(repayments) under paa commercial paper program (note6)
-1,086
116
970
-462
Repayment under paa term loan (note6)
1,100
-
1,114
-
Borrowing under paa term loan (note 11)
-
-
1,100
-
Proceeds from the issuance of paa senior notes (note 11)
-
-
752
1,248
Repayments of paa senior notes (note 6)
750
-
1,000
-
Repurchase of common units by a subsidiary
-
-
-
0
Repurchase of common units by a subsidiary (note 12)
-
-
8
-
Repurchase of series a preferred units by a subsidiary (note7)
0
0
0
0
Distributions paid to class a shareholders (note7)
82
83
76
75
Distributions paid to noncontrolling interests (note7)
366
368
354
356
Contributions from noncontrolling interests
0
0
41
5
Other financing activities
-2
-4
-18
-42
Net cash provided by/(used in) financing activities
-3,386
-339
301
318
Effect of translation adjustment - continuing operations
-13
-3
1
5
Effect of translation adjustment - discontinued operations
0
0
0
-11
Net increase in cash and cash equivalents and restricted cash
888
-157
-852
721
Cash and cash equivalents and restricted cash, beginning of period
172
329
1,181
349
Cash and cash equivalents and restricted cash, end of period
1,060
172
329
1,181
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,815M
(134.19%↑ Y/Y)
Changes in assets and
liabilities, net of...
-$244M
(-274.29%↓ Y/Y)
Depreciation and
amortization
$243M
(-47.85%↓ Y/Y)
Distributions on earnings from
unconsolidated entities
$107M
(-58.20%↓ Y/Y)
Deferred income tax
expense/(benefit)
$102M
(155.00%↑ Y/Y)
Losses on asset sales,
asset impairments and...
-$59M
(-103.45%↓ Y/Y)
Cash provided
by/(used in) investing...
$3,467M
(3370.75%↑ Y/Y)
Cash provided by
operating activities -...
$811M
(-21.19%↓ Y/Y)
Cash provided by
operating activities -...
$141M
(-53.16%↓ Y/Y)
Canceled cashflow
$1,759M
Current income tax
expense
$71M
Net cash provided
by/(used in) investing...
$3,335M
(405.12%↑ Y/Y)
Net cash provided by
operating activities
$952M
(-28.42%↓ Y/Y)
Canceled cashflow
$132M
Income from
discontinued operations, net...
$1,651M
(701.46%↑ Y/Y)
Equity earnings in
unconsolidated entities
$89M
(-54.59%↓ Y/Y)
(gain)/loss on foreign
currency revaluation
$16M
(500.00%↑ Y/Y)
Other
$3M
(109.38%↑ Y/Y)
Cash received from
sales of linefill
$37M
Other investing
activities
-$20M
Proceeds from sales of
assets
$1M
(-95.24%↓ Y/Y)
Canceled cashflow
$71M
Net increase in cash
and cash...
$888M
(700.00%↑ Y/Y)
Canceled cashflow
$3,399M
Cash used in
investing activities -...
-$132M
(86.63%↑ Y/Y)
Canceled cashflow
$58M
Income from
discontinued operations...
$1,625M
Deferred income tax
(expense)/benefit
-$38M
Purchases and related
costs
$205M
Field operating costs
$108M
General and
administrative expenses
$17M
Net cash provided
by/(used in) financing...
-$3,386M
(-2235.17%↓ Y/Y)
Effect of translation
adjustment - continuing...
-$13M
(-262.50%↓ Y/Y)
Additions to property,
equipment and other
$138M
(-55.48%↓ Y/Y)
Cash paid in
connection with...
$42M
(-93.83%↓ Y/Y)
Cash paid for
purchases of linefill
$10M
(-41.18%↓ Y/Y)
Total costs and
expenses
-$1,275M
Total revenues
$350M
Canceled cashflow
$330M
Repayment under paa term
loan (note6)
$1,100M
Net
borrowings/(repayments) under paa...
-$1,086M
(-1673.91%↓ Y/Y)
Repayments of paa senior
notes (note 6)
$750M
Distributions paid to
noncontrolling interests...
$366M
(-49.93%↓ Y/Y)
Distributions paid to class a
shareholders (note7)
$82M
(-45.33%↓ Y/Y)
Other financing
activities
-$2M
(89.47%↑ Y/Y)
(gains)/losses on asset sales
and other, net
$1,605M
Buy us a coffee
PLAINS GP HOLDINGS LP (PAGP)
PLAINS GP HOLDINGS LP (PAGP)